ASTRAVEUS
Astraveus is revolutionizing the field of CGT manufacturing with the Lakhesys™ platform, an end-to-end, cell foundry, that uses deep process optimization and single-use, microfluidic bioprocessors to deliver better results with reduced inputs. By removing the need for large-scale infrastructure, reducing costs, and overcoming the logistical challenges typically associated with CGT manufacturing, Astraveus is seeking to transform patient access to these life-changing therapies.
ASTRAVEUS
Industry:
Bioinformatics Biotechnology Life Science
Founded:
2016-07-07
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.astraveus.com
Total Employee:
11+
Status:
Active
Total Funding:
28.87 M EUR
Technology used in webpage:
CrUX Top 50m CrUX Dataset
Similar Organizations
Bright Peak Therapeutics
Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
FoRx Therapeutics
FoRx Therapeutics is a biotechnology company developing a new generation of cancer drugs focusing on novel DNA Replication Stress pathways.
Myeloid Therapeutics
Myeloid Therapeutics is an immunology company focused on combining immunologic insights with cutting-edge technologies.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Vittoria Biotherapeutics
Vittoria Biotherapeutics is a gene-edited cell therapeutics company.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bpifrance
Bpifrance investment in Grant - Astraveus
M Ventures
M Ventures investment in Seed Round - Astraveus
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Seed Round - Astraveus
AdBio partners
AdBio partners investment in Seed Round - Astraveus
Bpifrance Large Venture
Bpifrance Large Venture investment in Seed Round - Astraveus
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Astraveus
Key Employee Changes
| Date | New article |
|---|---|
| 2023-12-12 | Astraveus appoints Dr. Lars Henrik Peeck as Chief Business Development Officer |
| 2023-08-31 | Astraveus Appoints Microfluidic expert Etienne Fradet as Chief Technical Officer |
Official Site Inspections
http://www.astraveus.com Semrush global rank: 10.66 M Semrush visits lastest month: 210
- Host name: 185.181.132.235
- IP address: 185.181.132.235
- Location: Turkey
- Latitude: 41.0214
- Longitude: 28.9948
- Timezone: Europe/Istanbul
More informations about "Astraveus"
Astraveus - Enable a Healthier Tomorrow
Astraveus welcomes industry leader David Newble to Advisory Board Astraveus is excited to welcome seasoned Life Science executive David Newble as new member of its Advisory …See details»
Astraveus - Crunchbase Company Profile & Funding
Additionally, Astraveus received a €10.4 million grant from the French government, further bolstering its financial resources for advancing its manufacturing solutions. These grants are …See details»
About Astraveus - Enable a Healthier Tomorrow
Apr 17, 2024 "Astraveus imagines, conceptualizes, develops and implements the technological innovations of the future that are necessary for the wider application of cell and gene therapies. We are delighted to support the team of …See details»
Astraveus - Funding, Financials, Valuation & Investors - Crunchbase
Astraveus is developing the next generation of cell and gene therapy (CGT) manufacturing solutions. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Astraveus Company Profile 2024: Valuation, Funding & Investors
Astraveus General Information Description. Developer of a cell foundry platform designed to provide affordable biological therapies and minimize environmental impact. The company's …See details»
Contact Astraveus - Enable a Healthier Tomorrow
ASTRAVEUS SAS 79, Avenue de Fontainebleau 94270 Le Kremlin-Bicêtre France. T: +33 1 84 23 00 06. M: [email protected]. Join Astraveus. Discover your Role. Embark on a …See details»
Astraveus - M Ventures
Astraveus’ cell foundries miniaturize and automate cell and gene therapy manufacturing in a unique, modular, end-to-end, microfluidic solution that mimics the elegance of natural systems. …See details»
Astraveus Company Overview, Contact Details & Competitors
Oct 24, 2023 Advanced Biotech Solutions Astraveus specializes in cutting-edge equipment for cell and gene therapy development, creating opportunities to supply advanced biotech …See details»
Astraveus - Contacts, Employees, Board Members, Advisors
Organization. Astraveus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 5. About. Astraveus has 3 current employee profiles, including …See details»
ASTRAVEUS - Societe.com
ASTRAVEUS, société par actions simplifiée, au capital social de 981545,50 EURO, dont le siège social est situé au 79 AVENUE DE FONTAINEBLEAU, 94270 LE KREMLIN-BICETRE, …See details»
Astraveus - Company Profile - Tracxn
Astraveus - Provider of a device for autologous cell and gene therapies. Raised a total funding of $18M over 3 rounds from 6 investors. Founded by Jeremie Laurent in the year 2016. …See details»
Astraveus - VentureRadar
LAKHESYS by ASTRAVEUS is an Integrated Microfluidic Production Solution for Cell and Gene Therapies, From Research to Industrial Stages. Lakhesys instrument is an automated closed …See details»
ASTRAVEUS Company Profile | PARIS, ILE DE FRANCE, France
Find company research, competitor information, contact details & financial data for ASTRAVEUS of PARIS, ILE DE FRANCE. Get the latest business insights from Dun & Bradstreet.See details»
Astraveus Company Profile - Office Locations, Competitors ... - Craft
Astraveus is a company that specializes in integrated microfluidic bioproduction. It offers high tech equipment to manufacture autologous cell and gene therapies. The company uses microfluidic …See details»
People - Astraveus - We strive to enable a healthier tomorrow
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of …See details»
News Astraveus - Astraveus - Enable a Healthier Tomorrow
Nov 28, 2023 Astraveus is excited to welcome seasoned Life Science executive David Newble as new member of its Advisory Board. Keep Reading. 02.08.2024; Announcement. Cell …See details»
Astraveus Company Information - Funding, Investors, and More
The company Astraveus has raised a total of $18.05m in funding over 1 rounds. Key Insights: Seed: $18.05m; 2024. Astraveus Seed (2023, $18M) $18.05m. Discover Astraveus. Company …See details»
Astraveus raises 16.5 Million Series Seed round to advance the ...
Astraveus is a Paris-based company, founded in 2016 by Jérémie Laurent at the St Louis Hospital. Astraveus is a member of the #FrenchTech2030, a program by La French Tech, …See details»
Astraveus Careers - Levels.fyi
ASTRAVEUS is a biotechnology firm focused on modular, microfluidic cell foundries for cell and gene therapy manufacturing. Their Lakhesys™ platform employs deep process optimization …See details»
Press Release - Astraveus - We strive to enable a healthier tomorrow
Astraveus appoints Michel Spagnol as Chairman of the Board. Michel Spagnol to lead board, focusing on transformative CGT tech. Keep Reading. 19.09.2023; Press Release. French …See details»